Despite 2020 being the strangest and least predictable year ever, Enantis managed to fulfil its goals.

We have managed to secure a global license agreement to reach even more customers with our FGF2-STAB in the years to come. Moreover, we have been officially granted a European patent covering the FGF2-STAB invention and more patents in other territories are pending. Also, we were working hard on other molecules from our pipeline to bring new products to the market soon.

As everyone this year, we hope 2021 proves to be game-changing and very different from 2020 and we are ready to make the best out of it.

No matter the altered circumstances, we wish you a lovely Christmas time and a happy New Year.